Macsot, Jenicel T.
HRN: 29-48-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2026
CEFTRIAXONE 1G (VIAL)
08/17/2026
08/24/2026
IV
1g
Q24
PCAP
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: